Botanical species · safety record

Ipomoea orizabensis

The EFSA Compendium of Botanicals holds 7 constituent measurements for Ipomoea orizabensis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea orizabensis (G. Pelletan) Ledeb. ex Steud.

7Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Glucoresins	Roots and other underground parts	—	—	—	Resolve DOI
Scammonin i	Roots and other underground parts	—	—	—	Resolve DOI
Scammonin ii	Roots and other underground parts	—	—	—	Resolve DOI
Scopoletin	Roots and other underground parts	Solvent extraction	—	Unspecified	Resolve DOI
Ergoline alkaloids	Seed	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Ergoline alkaloids	Stem / stalk	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Lysergic acid	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Meira, M., da Silva, E.P., David, J.M., David, J.P. Review of the genus Ipomoea: Traditional uses, chemistry and biological activities. Brazilian journal of pharmacognosy, 2012, vol. 22, no. 3, p. 682-713. DOI
Garcia Argarez, A. Garcia., Perez-Amador, M. C. Distribution in the plant of glycoresins and ergoline alkaloids in three species of Ipomoea (Convolvulaceae). Phyton (Buenos Aires), 1997, vol. 60, no. 1-2, p. 73-76.
Power, F.B., Rogerson, H. I. - Chemical examination of the root of Ipomoea orizabensis. Journal of the chemical society, transactions, 1912, vol. 101, p. 1-26. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature